Zobrazeno 1 - 10
of 1 845
pro vyhledávání: ''
Publikováno v:
European Psychiatry. 60:41-48
Background:Current treatments for smoking cessation are not effective for most smokers. This study aims to examine the effectiveness of transcranial Direct Current Stimulation (tDCS) on smoking cessation.Methods:In this randomized, sham-controlled tr
Autor:
Kristina Adorjan, Michael Soyka, Gabi Koller, Felicia Kamp, Joseph Kambeitz, Daniela Krause, Oliver Pogarell, Lisa Proebstl, Peter Falkai, Kirsi Manz
Publikováno v:
European Psychiatry. 59:15-24
Background:Stimulant drugs can cause persistent changes in the brain. Imaging studies show that these changes are most apparent in dopamine transporter (DAT) or receptor availability within the striatum.Methods:This work focuses on influences of stim
Autor:
Katharina Burda, Katrin Druschky, Alexandra Neyazi, Helge Frieling, Thomas Hillemacher, Sermin Toto, Renate Grohmann, Susanne Stübner, Stefan Bleich
Publikováno v:
European Psychiatry. 54:117-123
Background:The study aimed to investigate severe hair loss related to psychotropic drugs (PDs) by using data from the drug safety programme Arzneimittelsicherheit in der Psychiatrie (AMSP).Methods:Data on PD utilization and reports of severe PD-relat
Autor:
Sverre Wikström, Shanna H. Swan, Carl-Gustaf Bornehag, Holger M. Koch, M. Unenge Hallerback, Avi Reichenberg, Bo Jönsson
Publikováno v:
European Psychiatry. 51:98-103
Objective:To examine prenatal APAP exposure in relation to language development in offspring at 30 months of age.Method:A population-based pregnancy cohort study including 754 women who enrolled in the Swedish Environmental Longitudinal, Mother and c
Publikováno v:
European Psychiatry. 42:129-133
BackgroundThere are no data on age-related pharmacotherapy for Attention Deficit Hyperactivity Disorder (ADHD) medication in children and adolescents in the most European countries. The main aim of this paper was to obtain that data for children and
Publikováno v:
European Psychiatry. 62:58-59
Use of atypical antipsychotics (AAPs) for attention-deficit/hyperactivity disorder (ADHD) is currently rife and trend of use is on the rise. It is largely off-label driven. Here, we touch on the topic highlighting both merits and demerits of this app
Publikováno v:
European Psychiatry. 33:61-67
BackgroundA post-authorisation safety study was carried out as part of the EU Risk Management Plan to examine the long-term (up to 12 months) use of quetiapine XL as prescribed in general practice in England.AimTo present a description of the drug ut
Publikováno v:
European Psychiatry. 55:43-44
Autor:
Yongcai Mao, Jane Xu, Josephine Cucchiaro, Stephen R. Marder, Robert Silva, Antony Loebel, Andrei Pikalov
Publikováno v:
European Psychiatry. 30:26-31
Objective:To evaluate the efficacy of lurasidone for schizophrenia using an established five-factor model of the Positive and Negative Syndrome Scale (PANSS).Methods:Patient-level data were pooled from five randomized, double-blind, placebo-controlle
Autor:
Benoît Delatte, Frank Kok, B. Gillain, J.-Y. Loze, Veronique Halkin, G. Touquet, A de Patoul, Chris Bervoets, Kristof Vansteelandt, Jozef Peuskens, Eric Constant
Publikováno v:
European Psychiatry. 27:506-512
PurposeThe aim of this study is to evaluate the effectiveness of 12-week treatment with aripiprazole in a broad range of patients suffering from schizophrenia by using a variety of physicians, caregivers and patients scales.Subjects and methodsA tota